New Strategy Captures Drug Maker's Interest
EMD Serono, Inc., agreed to provide Fast Forward, LLC, the Society's drug discovery subsidiary, with up to $19 million for early stage clinical development projects.
Read more >>
New Strategy Captures Drug Maker's Interest
EMD Serono, Inc., agreed to provide Fast Forward, LLC, the Society's drug discovery subsidiary, with up to $19 million for early stage clinical development projects.
Read more >>
============================================